Moderna Gross Profit vs. Price To Book

M1RN34 Stock  BRL 12.10  0.05  0.41%   
Based on the key profitability measurements obtained from Moderna's financial statements, Moderna may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Moderna's ability to earn profits and add value for shareholders.
For Moderna profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Moderna to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Moderna utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Moderna's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Moderna over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moderna is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Moderna Price To Book vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Moderna's current stock value. Our valuation model uses many indicators to compare Moderna value to that of its competitors to determine the firm's financial worth.
Moderna is regarded fifth in gross profit category among its peers. It also is regarded fifth in price to book category among its peers . The ratio of Gross Profit to Price To Book for Moderna is about  3,125,676,407 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Moderna by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Moderna's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Moderna Price To Book vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Moderna

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
13.86 B
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Moderna

P/B

 = 

MV Per Share

BV Per Share

 = 
4.44 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Moderna Price To Book Comparison

Moderna is regarded fourth in price to book category among its peers.

Moderna Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Moderna, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Moderna will eventually generate negative long term returns. The profitability progress is the general direction of Moderna's change in net profit over the period of time. It can combine multiple indicators of Moderna, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. MODERNA INC operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 1800 people.

Moderna Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Moderna. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Moderna position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Moderna's important profitability drivers and their relationship over time.

Use Moderna in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Moderna position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will appreciate offsetting losses from the drop in the long position's value.

Moderna Pair Trading

Moderna Pair Trading Analysis

The ability to find closely correlated positions to Moderna could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Moderna when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Moderna - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Moderna to buy it.
The correlation of Moderna is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Moderna moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Moderna moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Moderna can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Moderna position

In addition to having Moderna in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Farming Thematic Idea Now

Farming
Farming Theme
Companies producing farming products and providing services for farmers. The Farming theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Moderna Stock

When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:
Check out Correlation Analysis.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
To fully project Moderna's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Moderna at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Moderna's income statement, its balance sheet, and the statement of cash flows.
Potential Moderna investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Moderna investors may work on each financial statement separately, they are all related. The changes in Moderna's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Moderna's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.